Treatment decision making and genetic testing for breast cancer: Mainstreaming mutations

JAMA - Journal of the American Medical Association

Volumn 314, Issue 10, 2015, Pages 997-998

  Katz, Steven J ^a   Kurian, Allison W ^b   Morrow, Monica ^c,d  

^a UNIVERSITY OF MICHIGAN   (United States)

^b STANFORD UNIVERSITY   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CLINICAL DECISION MAKING; CONTRALATERAL PROPHYLACTIC MASTECTOMY; DISEASE MARKER; GENE IDENTIFICATION; GENE MUTATION; GENETIC SCREENING; HUMAN; MASTECTOMY; MEDICAL INFORMATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SHORT SURVEY; TREATMENT PLANNING; TUMOR SUPPRESSOR GENE; BREAST NEOPLASMS; DECISION MAKING; FEMALE; GENETIC COUNSELING; GENETICS; GERMLINE MUTATION; MUTATION; NEOPLASMS, SECOND PRIMARY; TRENDS;

BREAST NEOPLASMS; DECISION MAKING; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC TESTING; GERM-LINE MUTATION; HUMANS; MASTECTOMY; MUTATION; NEOPLASMS, SECOND PRIMARY;

EID: 84941661791     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.8088     Document Type: Short Survey

References (8)

1. Jagsi R, Kurian AW, Griffith KA, et al. Genetic testing decisions of breast cancer patients: results from the iCanCare study. Abstract presented at: The American Society of Clinical Oncology Annual Meeting; June 2015; Chicago, Illinois.
2. Hooker GW, Nagy R, Buchanan A, et al. Cancer genetic counseling and testing in an era of rapid change. Abstract presented at: The American College of Medical Genetics Annual Meeting; March 25, 2014; Nashville, Tennessee.
3. Morrow M, Waters J, Morris E. MRI for breast cancer screening, diagnosis, and treatment. Lancet. 2011; 378(9805): 1804-1811.
4. Nichols HB, Berrington de González A, Lacey JV Jr, Rosenberg PS, Anderson WF. Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. J Clin Oncol. 2011;29(12):1564-1569.
5. Tuttle TM, Habermann EB, Grund EH, Morris TJ, Virnig BA. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25(33):5203-5209.
6. Maxwell KN, Wubbenhorst B, D'Andrea K, et al. Prevalence of mutations in a panel of breast cancer susceptibility genes in BRCA1/2-negative patients with early-onset breast cancer [published online December 11, 2014]. Genet Med. doi:10.1038/gim.2014.176.
7. Easton DF, Pharoah PD, Antoniou AC, et al. Gene-panel sequencing and the prediction of breast-cancer risk. N Engl J Med. 2015;372(23): 2243-2257.
8. Kurian AW, Ford JM. Multigene panel testing in oncology practice: how should we respond? JAMA Oncol. 2015;1(3):277-278.